Enlivex Ltd (ENLV) Stock Price, Quote, News & History

ENLVNASDAQ
$1.58
0.063.95%
Last update: Aug 19, 12:59 PM

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-10.42M
Investing Cash Flow (TTM)
-1.32M
Financing Cash Flow (TTM)
10.38M
Free Cash Flow (TTM)
-10.48M
Capital Expenditure (TTM)
-68.00K
Net Change in Cash (TTM)
-1.36M

Analyst Trends and Forecast

1
Apr
1
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$21.46M
PE Ratio (TTM)
0.00
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
0.01
Earnings Yield % (TTM)
25144.74%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$110.66

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$1.89M
Debt to Equity
0.00
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$1.50
Close
-
Volume / Avg.
123.70K / 172.41K
Day Range
$1.47 - $1.64
52 Wk Range
1.48 - 27.15
Market Cap
$27.63M
P/E Ratio
0.00
Dividend Yield
-
Exchange
NASDAQ
RSI
15
Short Interest
1.02%
Days to Cover
1

About

Sector
Health Care
Industry
Biotechnology
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Enlivex (ENLV) stock?

A

You can purchase shares of Enlivex (NASDAQ:ENLV) through any online brokerage.

View our list of the best stock brokerages

Q

What is the forecast, or price target, for Enlivex (ENLV) stock?

A

Enlivex has a consensus price target of $46.50.

Q

What is the current price for Enlivex (ENLV)?

A

The stock price for Enlivex (NASDAQ: ENLV) is $1.58 last updated August 19, 2026 at 12:59 PM EDT.

Q

Does Enlivex (ENLV) pay a dividend?

A

There are no upcoming dividends for Enlivex.

Q

When is Enlivex (NASDAQ:ENLV) reporting earnings?

A

Enlivex does not have any upcoming earnings scheduled.

Q

Is Enlivex (ENLV) going to split?

A

There is no upcoming split for Enlivex.

Q

What sector and industry does Enlivex (ENLV) operate in?

A

Enlivex is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.